GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (NAS:SNY) » Definitions » 3-Year Book Growth Rate

SNY (Sanofi) 3-Year Book Growth Rate : 2.50% (As of Jun. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Sanofi 3-Year Book Growth Rate?

Sanofi's Book Value per Share for the quarter that ended in Jun. 2024 was $31.27.

During the past 12 months, Sanofi's average Book Value per Share Growth Rate was 0.10% per year. During the past 3 years, the average Book Value per Share Growth Rate was 2.50% per year. During the past 5 years, the average Book Value per Share Growth Rate was 5.30% per year. During the past 10 years, the average Book Value per Share Growth Rate was 3.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Sanofi was 58.60% per year. The lowest was 0.50% per year. And the median was 4.50% per year.


Competitive Comparison of Sanofi's 3-Year Book Growth Rate

For the Drug Manufacturers - General subindustry, Sanofi's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanofi's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Sanofi's 3-Year Book Growth Rate falls into.



Sanofi 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Sanofi  (NAS:SNY) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Sanofi 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Sanofi's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi Business Description

Address
46, avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Sanofi Headlines

From GuruFocus

Sanofi SA's Dividend Analysis

By GuruFocus Research 05-08-2024

Q4 2022 Sanofi SA Earnings Call Transcript

By GuruFocus Research 02-09-2024

Sanofi SA at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 02-09-2024

Q2 2024 Sanofi SA Earnings Call Transcript

By GuruFocus Research 07-26-2024

Sanofi SA at Citi BioPharma Conference Transcript

By GuruFocus Research 02-09-2024

Sanofi SA Vaccines Investor Event Transcript

By GuruFocus Research 02-09-2024